Rehabilitation

Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis

Abstract Background Motor neuron disease (MND), also known as amyotrophic lateral sclerosis (ALS), is a progressive neurodegenerative condition that may cause dysphagia, as well as limb weakness, dysarthria, emotional lability, and respiratory failure. Since normal salivary production is 0.5 L to 1.5 L daily, loss of salivary clearance due to dysphagia leads to salivary pooling […]

Share

Occupational therapy for cognitive impairment in stroke patients

Abstract Background Cognitive impairment is a frequent consequence of stroke and can impact on a person’s ability to perform everyday activities. Occupational therapists use a range of interventions when working with people who have cognitive impairment poststroke. This is an update of a Cochrane Review published in 2010. Objectives To assess the impact of occupational […]

Share

Environmental enrichment for stroke and other non‐progressive brain injury

Abstract Background Rehabilitation is effective for recovery after stroke and other non‐progressive brain injuries but it is unclear if the rehabilitation environment itself, outside of limited therapy hours, is maximally conducive to recovery. Environmental enrichment is a relatively new concept within rehabilitation for humans. In this review, this is defined as an intervention designed to […]

Share

Information provision for stroke patients and their caregivers

Abstract Background A stroke is a sudden loss of brain function caused by lack of blood supply. Stroke can lead to death or physical and cognitive impairment and can have long lasting psychological and social implications. Research shows that stroke survivors and their families are dissatisfied with the information provided and have a poor understanding […]

Share

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery

Abstract Background Selective serotonin reuptake inhibitors (SSRIs) might theoretically reduce post‐stroke disability by direct effects on the brain. This Cochrane Review was first published in 2012 and last updated in 2019. Objectives To determine if SSRIs are more effective than placebo or usual care at improving outcomes in people less than 12 months post‐stroke, and […]

Share

Botulinum toxin type A versus anticholinergics for cervical dystonia

Abstract Background This is an update of a Cochrane Review first published in 2005. Cervical dystonia is the most common form of focal dystonia and is a highly disabling movement disorder, characterised by involuntary, usually painful, head posturing. Currently, botulinum toxin type A (BtA) is considered the first line therapy for this condition. Before BtA, […]

Share

Prevention of depression in adults with long-term physical conditions

Abstract Background Major depression is one of the world’s leading causes of disability in adults with long‐term physical conditions compared to those without physical illness. This co‐morbidity is associated with a negative prognosis in terms of increased morbidity and mortality rates, increased healthcare costs, decreased adherence to treatment regimens, and a substantial decline in quality […]

Share

Patient and lay carer education for preventing pressure ulceration in at-risk populations

Abstract Background Pressure ulcers (PUs) are injuries to the skin and underlying tissues that occur most commonly over bony prominences, such as the hips and heels as a result of pressure and shear forces. PUs cause pain, discomfort, longer hospital stays, and decreased quality of life. They are also very costly to treat and consume […]

Share

Interventions for improving oral health in people after stroke

Abstract Background For people with physical, sensory and cognitive limitations due to stroke, the routine practice of oral health care (OHC) may become a challenge. Evidence‐based supported oral care intervention is essential for this patient group. Objectives To compare the effectiveness of OHC interventions with usual care or other treatment options for ensuring oral health […]

Share

Botulinum toxin type A therapy for blepharospasm

Abstract Background This is an update of a Cochrane Review first published in 2005. Blepharospasm is the second most common form of focal dystonia. It is a disabling disorder, characterised by chronic, intermittent or persistent, involuntary eyelid closure, due to spasmodic contractions of the orbicularis oculi muscles. Currently, botulinum toxin type A (BtA) is considered […]

Share
  • The review abstracts published on this site are the property of John Wiley & Sons, Ltd., and of the Cochrane Review Groups that have produced the reviews.
Share
Share